Advances in cardiac tissue engineering and heart‐on‐a‐chip

J Kieda, A Shakeri, S Landau, EY Wang… - … Research Part A, 2024 - Wiley Online Library
Recent advances in both cardiac tissue engineering and hearts‐on‐a‐chip are grounded in
new biomaterial development as well as the employment of innovative fabrication …

Biofabrication strategies for cardiac tissue engineering

S Okhovatian, R Khosravi, EY Wang, Y Zhao… - Current Opinion in …, 2024 - Elsevier
Highlights•Biofabrication enables creation of cardiac tissue for drug testing and
implantation.•3D printing provides unique solution for tissue vascularization.•Translational …

[HTML][HTML] Advancing Human iPSC-Derived Cardiomyocyte Hypoxia Resistance for Cardiac Regenerative Therapies through a Systematic Assessment of In Vitro …

CA Snyder, KD Dwyer, KLK Coulombe - International Journal of …, 2024 - mdpi.com
Acute myocardial infarction (MI) is a sudden, severe cardiac ischemic event that results in
the death of up to one billion cardiomyocytes (CMs) and subsequent decrease in cardiac …

Patterned Arteriole-Scale Vessels Enhance Engraftment, Perfusion, and Vessel Branching Hierarchy of Engineered Human Myocardium for Heart Regeneration

RJ Kant, KD Dwyer, JH Lee, C Polucha, M Kobayashi… - Cells, 2023 - mdpi.com
Heart regeneration after myocardial infarction (MI) using human stem cell-derived
cardiomyocytes (CMs) is rapidly accelerating with large animal and human clinical trials …

Engineered heart tissue: Design considerations and the state of the art

I Gokhan, TS Blum, SG Campbell - Biophysics Reviews, 2024 - pubs.aip.org
Originally developed more than 20 years ago, engineered heart tissue (EHT) has become
an important tool in cardiovascular research for applications such as disease modeling and …